Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma.
Sakai C, Matsuyama M, Nakajima M, Matsumura S, Nonaka M, Arai N, Kuramoto K, Yoshida K, Morishima Y, Muratani M, Hizawa N.
Sakai C, et al. Among authors: kuramoto k.
Allergol Int. 2024 Apr 5:S1323-8930(24)00043-1. doi: 10.1016/j.alit.2024.03.005. Online ahead of print.
Allergol Int. 2024.
PMID: 38582716
Free article.
No abstract available.